David A. Siegel Anixa Biosciences Inc Transaction History

Two Sigma Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $36,816 - $59,195	-14,438 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.5 - $3.42 $93,500 - $127,908	-37,400 Reduced 72.15%	14,438 $40,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $5.5 $13,536 - $25,850	-4,700 Reduced 8.31%	51,838 $154,000
Q3 2021 Nov 15, 2021	SELL	$3.57 - $5.6 $18,207 - $28,560	-5,100 Reduced 8.27%	56,538 $270,000
Q2 2021 Aug 16, 2021	BUY	$3.46 - $4.92 $165,865 - $235,854	47,938 Added 349.91%	61,638 $239,000
Q1 2021 May 17, 2021	BUY	$3.27 - $7.14 $11,772 - $25,704	3,600 Added 35.64%	13,700 $64,000
Q4 2020 Feb 16, 2021	SELL	$1.94 - $3.19 $50,870 - $83,648	-26,222 Reduced 72.19%	10,100 $31,000
Q3 2020 Nov 16, 2020	BUY	$1.79 - $3.3 $65,016 - $119,862	36,322 New	36,322 $88,000

5.56M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $82.5M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.